Low-Value Prostate-Specific Antigen Test for Prostate Cancer Screening and Subsequent Health Care Utilization and Spending

• Published in: JAMA network open Vol. 5; no. 11; p. e2243449
• Main Authors: Kim, David D, Daly, Allan T, Koethe, Benjamin C, Fendrick, A Mark, Ollendorf, Daniel A, Wong, John B, Neumann, Peter J
• Format: Journal Article
• Language: English
• Published: United States American Medical Association 01.11.2022
• Subjects: Aged; Aged, 80 and over; Cross-Sectional Studies; Early Detection of Cancer; Health Policy; Humans; Male; Medicare Part C; Online Only; Original Investigation; Patient Acceptance of Health Care; Prostate-Specific Antigen; Prostatic Neoplasms - epidemiology; United States; United States

Delivering low-value care can lead to unnecessary follow-up services and associated costs, and such care cascades have not been well examined in common clinical scenarios. To evaluate the utilization and costs of care cascades of prostate-specific antigen (PSA) tests for prostate cancer screening, a...